ImmunityBio has surged over 200% YTD, yet I see little fundamental justification for its current $10B enterprise value. Click here to read why IBRX is a Sell.
A Hybrid Machine Learning Framework for Early Diabetes Prediction in Sierra Leone Using Feature Selection and Soft-Voting Ensemble ...
Call it a side hustle or, more precisely, a “side hustle on steroids” to quote Queens-born Joe Macken, who spent 21 years hand-crafting a miniature model of ...
SHENZHEN, GUANGDONG, CHINA, January 21, 2026 /EINPresswire.com/ -- In an increasingly competitive home fragrance and ...
FREDERICK, MD, UNITED STATES, January 21, 2026 /EINPresswire.com/ — MSTRO, Inc., a developer of AI-augmented intelligence platforms, and DataCorps Technology Solutions, a leadin ...
A Purdue University digital forestry team has created a computational tool to obtain and analyze urban tree inventories on ...
Joe Macken has been a truck driver for more than 18 years. He delivers for a beverage company along a 200-mile route four ...
After decades, scientists have finally pieced together the 23-step biosynthetic pathway to produce this cancer drug ...
Before dealers head to the NADA Show, evidence mounts that AI is already cutting costs and improving efficiency in ...
The small modular reactor (SMR) nuclear energy company is down 70% from its recent peak.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results